Company profile: Minakem
1.1 - Company Overview
Company description
- Provider of pharmaceutical intermediates and active pharmaceutical ingredients for life sciences industries, offering API manufacturing for innovative and generic drugs, including highly potent APIs; custom development and manufacturing; production of key intermediates; comprehensive analytical services from substance development to marketing authorization; and corticosteroid API manufacturing at a Montreal facility.
Products and services
- Analytical Services: Offers market-authorization-focused analytical services covering the continuum from drug substance development to drug product marketing authorization for pharmaceutical intermediates and APIs
- API Manufacturing: Produces active pharmaceutical ingredients for innovative and generic drugs, including highly potent APIs, with highly potent-enabled capability for life sciences industry applications
- Custom Manufacturing: Builds custom-engineered manufacturing services for pharmaceutical intermediates and APIs, tailored to specific project needs within drug substance development and pharmaceutical manufacturing in the life sciences industries
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Minakem
Two Labs
HQ: United States
Website
- Description: Provider of pharmaceutical services including market access, market intelligence, commercialization, and medical affairs & communications for pharmaceutical manufacturers. Offerings include channel strategy, state licensing, compendia listings, publication support, payer/physician/patient strategies, disease and competitor insights, Riparian government pricing/contracting/transparency, and specialty pharmacy network selection; led 200+ launches and 290+ in-market projects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Two Labs company profile →
Cody Labs
HQ: United States
Website
- Description: Provider of active pharmaceutical ingredients (APIs) and finished dosage forms of pain relief medication, as well as CodyLabs – Cinema Browser, a web browser for movie enthusiasts with integration to streaming services, support for various video formats, automatic subtitle synchronization, and picture-in-picture mode.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cody Labs company profile →
Presidio Medical
HQ: United States
Website
- Description: Provider of a transformational neuromodulation platform and ULF Neuromodulation Therapy, which uses ultra low frequency current waveforms to inhibit pain signals; shown effective in clinical trials for chronic pain without causing paresthesia, enabling remedies for disorders affecting neuronal activity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Presidio Medical company profile →
Core Diagnostics
HQ: United States
Website
- Description: Provider of full-service esoteric pathology laboratory services; a venture capital-backed laboratory based in Hayward, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Core Diagnostics company profile →
Althea Technologies
HQ: United States
Website
- Description: Provider of contract manufacturing services to the pharmaceutical and biotechnology industries, offering gene expression analysis via eXpress Profiling, quantitative PCR testing, cGMP drug product filling in vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Althea Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Minakem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Minakem
2.2 - Growth funds investing in similar companies to Minakem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Minakem
4.2 - Public trading comparable groups for Minakem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →